Having trouble accessing articles? Reset your cache.

Elinogrel: Phase II data

In the double-blind, international Phase II INNOVATE-PCI trial in about 650 patients undergoing non-urgent PCI, 100 and 150 mg doses of elinogrel produced a

Read the full 245 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE